|
Market Closed -
Budapest S.E.
11:19:59 2026-10-09 EDT
|
5-day change | 1st Jan Change | ||
| 12,350.00 HUF | +1.23% |
|
-0.40% | +25.19% |
| 09-18 | EU Medicines Agency Panel Issues Positive Opinion on Gedeon Richter's Arthritis Drug | MT |
| 08-11 | Gedeon Richter PLC, Q2 2026 Earnings Call, Aug 07, 2026 |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | 13,214.57 | +8.32% | 7 | ||||||
| 1,330.25 | +13.74% | 29 | ||||||
| 279.64 | +9.03% | 22 | ||||||
| 281.5 | +3.33% | 28 | ||||||
| 157.28 | +10.46% | 25 | ||||||
| 376.18 | +6.66% | 19 | ||||||
| 150.55 | +6.54% | 22 | ||||||
| 209.51 | +33.32% | 23 | ||||||
| 393.87 | -3.33% | 29 | ||||||
| 159.38 | +8.35% | 26 | ||||||
| 305.82 | +22.38% | 23 | ||||||
| 29.11 | +4.62% | 26 | ||||||
| 571.61 | +13.58% | 28 | ||||||
| 65.92 | +10.64% | 24 | ||||||
| 980.67 | +5.42% | 12 | ||||||
| 94.06 | +32.61% | 24 | ||||||
| 21.73 | +25.2% | 21 | ||||||
| 121 | -38.58% | 18 | ||||||
| 859.04 | +16.15% | 26 | ||||||
| 154.21 | +13.64% | 14 | ||||||
| Average | 987.79 | +10.10% | 22 | ||||||
| Weighted average by Cap. | 518.84 | +10.47% | 25 |
- Stock Market
- Stocks
- RICHTER Stock
- Sector Gedeon Richter
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
